{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T10:38:46Z","timestamp":1786358326815,"version":"build-2736575974"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1016\/j.ahj.2003.10.052","type":"journal-article","created":{"date-parts":[[2004,6,23]],"date-time":"2004-06-23T10:58:07Z","timestamp":1087988287000},"page":"91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Effect of pravastatin compared with placebo initiated within 24 hours of onset of acute myocardial infarction or unstable angina: The Pravastatin in Acute Coronary Treatment (PACT) trial"],"prefix":"10.1016","volume":"148","author":[{"given":"Peter L","family":"Thompson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Meredith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Amerena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence J","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.Graeme","family":"Sloman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip J","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2003.10.052_BIB1","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2003.10.052_BIB2","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels","volume":"335","author":"Sacks","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2003.10.052_BIB3","first-page":"1349","article-title":"Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels","volume":"339","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2003.10.052_BIB4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2003.10.052_BIB5","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1001\/jama.285.13.1758","article-title":"Lipid-lowering therapy in acute coronary syndromes","volume":"285","author":"Sacks","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2003.10.052_BIB6","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1161\/01.CIR.103.23.2768","article-title":"In-hospital initiation of lipid-lowering therapy for patients with coronary heart disease","volume":"103","author":"Fonarow","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2003.10.052_BIB7","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1001\/jama.285.4.430","article-title":"Early statin treatment following acute myocardial infarction and 1-year survival","volume":"285","author":"Stenestrand","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2003.10.052_BIB8","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1001\/jama.287.23.3087","article-title":"SYMPHONY and 2nd SYMPHONY Investigators","volume":"287","author":"Newby","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2003.10.052_BIB9","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0002-9149(00)01230-3","article-title":"Beneficial effects of pravastatin (+\/colestyramine\/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD]Study)","volume":"86","author":"Arntz","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2003.10.052_BIB10","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.285.13.1711","article-title":"Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators","volume":"285","author":"Schwartz","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2003.10.052_BIB11","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1742-1241.2001.tb11043.x","article-title":"Pravastatin in acute ischaemic syndromes","volume":"55","author":"Den Hartog","year":"2001","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.ahj.2003.10.052_BIB12","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0140-6736(96)90472-9","article-title":"Is vascular smooth muscle cell proliferation beneficial?","volume":"347","author":"Weissberg","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2003.10.052_BIB13","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1161\/01.CIR.103.2.276","article-title":"An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro","volume":"103","author":"Aikawa","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2003.10.052_BIB14","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0021-9150(95)05757-9","article-title":"Effects of pravastatin sodium and simvastatin on plasma fibrinogen level and blood rheology in type II hyperlipoproteinemia","volume":"122","author":"Tsuda","year":"1996","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ahj.2003.10.052_BIB15","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0140-6736(96)05190-2","article-title":"Statins do more than just lower cholesterol","volume":"348","author":"Vaughan","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2003.10.052_BIB16","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1161\/01.CIR.92.11.3172","article-title":"Hyperlipidemia and coronary disease","volume":"92","author":"Lacoste","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2003.10.052_BIB17","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1046\/j.1365-2362.2002.01086.x","article-title":"Time-dependent effect of statins on platelet function in hypercholesterolaemia","volume":"32","author":"Puccetti","year":"2002","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.ahj.2003.10.052_BIB18","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0021-9150(00)00370-1","article-title":"Effects of atorvastatin and vitamin C on endothelial function of hypercholesterolemic patients","volume":"152","author":"Perticone","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ahj.2003.10.052_BIB19","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/01.CIR.102.8.846","article-title":"Effect of cholesterol-lowering therapy on coronary endothelial vasomotor function in patients with coronary artery disease","volume":"102","author":"Vita","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2003.10.052_BIB20","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1161\/01.CIR.99.25.3227","article-title":"Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes","volume":"99","author":"Dupuis","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2003.10.052_BIB21","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1067\/mhj.2003.34","article-title":"Effect of atorvastatin and pravastatin on serum C-reactive protein","volume":"145","author":"Kent","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2003.10.052_BIB22","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/00041433-200212000-00006","article-title":"Early initiation of statin therapy after a coronary event","volume":"13","author":"McKeown","year":"2002","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.ahj.2003.10.052_BIB23","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1053\/euhj.2002.3291","article-title":"Fluvastatin On Risk Diminishment after Acute myocardial infarction study group","volume":"23","author":"Liem","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2003.10.052_BIB24","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1001\/jama.287.23.3087","article-title":"SYMPHONY and 2nd SYMPHONY Investigators","volume":"287","author":"Newby","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2003.10.052_BIB25","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Pravastatin or atorvastatin evaluation and infection therapy-Thrombolysis in Myocardial Infarction 22 Investigators.","volume":"350","author":"Cannon","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2003.10.052_BIB26","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1067\/mhj.2001.116959","article-title":"The A-to-Z trial","volume":"142","author":"Blazing","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2003.10.052_BIB27","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1161\/01.CIR.103.1.38","article-title":"Use of lipid-lowering medications at discharge in patients with acute myocardial infarction","volume":"103","author":"Fonarow","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2003.10.052_BIB28","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (ATP III)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2003.10.052_BIB29","unstructured":"Braunwald E, Antman EM, Beasley JW, et al. ACC\/AHA 2002 guideline update for the management of patients with unstable angina and non\u2013ST-segment elevation myocardial infarction: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). 2002. Available at: http:\/\/www.acc.org\/clinical\/guidelines\/unstable\/unstable.pdf"},{"key":"10.1016\/j.ahj.2003.10.052_BIB30","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0002-9149(00)01519-8","article-title":"Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP)","volume":"87","author":"Fonarow","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2003.10.052_BIB31","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1001\/archinte.162.4.468","article-title":"Impact of a targeted intervention on lipid-lowering therapy in patients with coronary artery disease in the hospital setting","volume":"162","author":"Lacy","year":"2002","journal-title":"Arch Intern Med"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870304001036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870304001036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:06:37Z","timestamp":1757567197000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870304001036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["S0002870304001036"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2003.10.052","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2004,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of pravastatin compared with placebo initiated within 24 hours of onset of acute myocardial infarction or unstable angina: The Pravastatin in Acute Coronary Treatment (PACT) trial","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2003.10.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}